Polypharmacy & Deprescribing – A Plan of Attack for MAPD Plans, Providers, & Pharmacists

The term “polypharmacy” has been around since the 1700s, but it’s only recently that it’s taken on a deeply negative connotation. Unfortunately, that connotation is warranted. “Overtreatment” with medically unnecessary drugs is a real problem in America and even around the world. It’s important to understand that polypharmacy isn’t a member or patient problem. It’s not a provider problem. It’s not even a pharmacy problem. It’s a problem that belongs to all of us in the healthcare industry, which is why we need to address it together. So, although last year we wrote about polypharmacy and emphasized the role of analytics in solving it, today we want to think bigger than that. If we want to really solve it, we’ll have to use analytics the way it was intended – leveraged as a powerful tool in a systematic approach.

Want to talk about how we do this? So do we.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.